Clinical assessment of akathisia, dystonia, parkinsonism, and TD should be conducted at baseline and at each follow-up visit.
Clinical assessment to screen for the development of TD in patients taking antipsychotics or other drugs with dopamine receptor blocking properties, regardless of the degree of risk for TD, should be performed at every clinical encounter.
aPatients at increased risk for developing abnormal involuntary movements include: individuals older than 55 years; women; individuals with a mood disorder, substance use disorder, intellectual disability, or central nervous system injury; individuals with high cumulative exposure to antipsychotic medications, particularly high-potency dopamine D2 receptor antagonists; and patients who experience acute dystonic reactions, clinically significant parkinsonism, or akathisia.1
1. American Psychiatric Association. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. American Psychiatric Association; 2020. 2. Caroff SN, Citrome L, Meyer J, et al. A modified Delphi consensus study
of the screening, diagnosis, and treatment of tardive dyskinesia. J Clin Psychiatry. 2020;81(2):19cs12983.